THROMBOLYSIS VS PCI IN EARLY PRESENTERS ( < 2 HOURS) Ian Agahari QUESTION Which reperfusion strategy prehospital fibrinolysis or primary PCI is more superior for patients with symptom to medical contact < 2 hours? TIME IS MUSCLE Delay in thrombolysis increases mortality Mortality at 35 days with thrombolysis depends on symptoms to treatment. Greatest benefit when thombolysis applied < 1 hour and no benefit is shown when thrombolysis is given > 12 hours DELAY IN PCI INCREASES MORTALITY TIME IS MUSCLE SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS PTCA THROMBOLYSIS SYSTEMATIC REVIEWS STUDIES Most trials are not transfer trials Most trials are not inhospital fibrinolysis vs PCI rather than prehospital fibrinolysis vs PCI Most trials do not compare the 2 treatments in context of symptom to treatment < 2 hours Only 7 trials are true transfer trials Only 3 trials have data for prehospital thrombolysis vs PCI trials Maarstrich; CAPTIM and 42% of patients in Swedes trial Apart from the CAPTIM trial, the other two studies are small in number. INDIVIDUAL STUDIES – DANAMI TRIAL INDIVIDUAL STUDIES – DANAMI II TRIAL LONG TERM FOLLOW UP. INDIVIDUAL STUDIES – GUSTO II B SYSTEMIC REVIEWS SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS Symptom to randomisation or admission Median Times and IQR: Both thrombolytic patients (414 patients) and PCI patients (424 patients) have a median symptom to randomisation of 80 min. Thrombolysis for early presenters (60:80:100) + 22 min PCI (60:82:100) + 69 min The majority of patients who present early has symptoms to treatment > 2 hours SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS SYSTEMATIC REVIEWS INDIVIDUAL STUDIES – CAPTIM TRIAL INDIVIDUAL STUDIES – CAPTIM TRIAL Patients who presents to MICU with STEMI No contraindications/ exclusion characteristics < 6 hours of chest pain < 1 hour for transfer to PCI centre. Primary outcome: Combined death, non fatal re-infarction, nonfatal ischemic stroke within 30 days Secondary outcome: Individual outcomes from composite Severe bleeding: Intracranial hemorrhage, hemodynamic compromise or requiring transfusion. INDIVIDUAL STUDIES – CAPTIM TRIAL The data was divided among early presenters (symptom to treatment < 2 hours) and late presenters (symptom to treatment > 2 hours) BASELINE CHARACTERISTICS – CAPTIM TRIAL 840 patients 421 to primary PCI and 419 to prehospital thrombolysis (Alteplase) with rescue PCI if necessary (decision given to investigator) 460 presented < 2 hours and 374 presented later than 2 hours Time of symptom to treatment < 2 hours Lysis < 2 hours PCI > 2 hour Lysis > 2 hours PCI 95 Min (40 – 175) 150 Min (82 – 260) 195 Min (120 – 570) 258 Min (150 – 1275) INDIVIDUAL STUDIES – CAPTIM TRIAL INDIVIDUAL STUDIES – CAPTIM TRIAL INDIVIDUAL STUDIES – CAPTIM TRIAL It is important to note that essential aspect of the CAPTIM trial is rescue PCI 26 % required rescue PCI 70% undegone PCI within 30 days Increase in patient in shock in early PCI group is a suprising finding not found previously in inhospital thrombolytic vs PCI studies LONG TERM FOLLOW UP CAPTIM TRIAL INDIVIDUAL STUDIES – CAPTIM TRIAL INDIVIDUAL STUDIES – PRAGUE 2 PROSPECTIVE REGISTRIES RIKS - HIA PROSPECTIVE REGISTRIES RIKS - HIA 26 205 consecutive patients from register of information and knowledge of swedish heart intensive care admissions. 16043 inpatient thrombolysis; 3078 patients prehospital thrombolysis and 7084 patients PCI. Up to 1 year of follow up. PROSPECTIVE REGISTRIES RIKS - HIA PROSPECTIVE REGISTRIES PROSPECTIVE REGISTRIES RIKS - HIA PROSPECTIVE REGISTRIES VIENNA PROSPECTIVE REGISTRIES VIENNA 1053 consecutive patients presenting to high volume PCI centres with experienced interventionalist on duty Treatment according to European guidelines. Door to balloon < 90 min Difference in door to balloon and door to needle time < 60 min Door to thrombolysis < 30 min Thrombolysis (in hospital or prehospital) if No contraindication to thrombolysis Present < 2-3 hours Door to balloon time > 90 minutes Rescue PCI if thrombolysis fails in 60 min PROSPECTIVE REGISTRIES - VIENNA PROSPECTIVE REGISTRIES - VIENNA MORTALITY BETWEEN INHOSPITAL AND PRESHOSPITAL THROMBOLYSIS SUMMARY OF CURRENT DATA Time is muscle: Delay in reperfusion increases mortality PCI is superior to thrombolysis if patients has pain more than 2-3 hours Preshopital thrombolysis and prehospital triage decrease time to reperfusion and therefore decrease mortality for those who don’t have access to PCI. Thrombolysis play a crucial role in reducing mortality in areas where PCI is not accessible within 90 min Controversy exist with patients who present < 2 hours. Despite this, PCI play a large role in this setting to prevent re-infarction and recurrent ischemia. JOHN HUNTER AREA JOHN HUNTER AREA POSSIBLE DELAYS Patients in peripheral hospital do not have priority for ambulance allocation as oppose to patients on the field Traffic on different times of day Ambulance workload